News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 762
- Sources here
- 26
- Companies here
- 17
Active search
762 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Analysts Offer Insights on Materials Companies: TRONOX (TROX) and Sylvamo Corp (SLVM)
Truist Financial analysts have provided updated ratings for two materials companies. Pete Osterland maintained a Hold rating on TRONOX (TROX) with a $7.00 price target, while Michael Roxland reiterated a Buy rating on Sylvamo Corp (SLVM) with a $49.00 price target. The article details …
Paramount Skydance (PSKY) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Executive Vice President of Corporate Finance and Investor Relations - Kevin CreightonChairman and Chief Executive Officer - David EllisonChief Financial Officer - Dennis CinelliChief Strategy and Operating Officer …
Sharemaestro market context Price below Trend Line 52 weeks -42.0% · Next-week setup negative 31.3%Black Diamond Settles HMI Cancer-Drug Discovery Patent Lawsuit
Black Diamond Therapeutics Inc. has settled a patent infringement lawsuit filed by HMI Medical Innovations LLC. HMI had alleged that Black Diamond's cancer therapy development infringed on six of its patents. The companies reached a confidential settlement and license agreement, leading to the dismissal …
Here's How Much $100 Invested In Diamondback Energy 5 Years Ago Would Be Worth Today
Diamondback Energy (NASDAQ: FANG) has significantly outperformed the market over the last five years, with an average annual return of 22.7%. An investment of $100 in FANG stock five years ago would now be worth $266.67, highlighting the power of compounded returns. The company …
Diamondback Energy Rose Almost 6% in a Day. Here’s Where the Stock Could Go in 2026
Diamondback Energy (FANG) saw a nearly 6% stock jump, largely driven by rising oil prices, after reporting strong Q2 results that beat revenue and earnings estimates. The company's management has focused on financial flexibility, debt reduction, and strategic share repurchases, rather than a fixed …
Sylvamo Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Sylvamo Corporation reported a surprise statutory loss of US$0.28 per share on revenues of US$806m for its second quarter, despite analysts expecting a profit. This led analysts to downgrade their earnings per share estimates for 2026, though revenue forecasts remained stable. The consensus price …
Crake Asset Management boosts Alphabet Class C stake by 411,000 shares
Crake Asset Management LLP, led by Richard Walker, has significantly increased its holdings in Alphabet Inc. Class C (GOOG) by acquiring an additional 411,000 shares. TipRanks' AI Analyst, Spark, rates GOOG as "Outperform" due to strong financial performance, a positive earnings outlook driven by …
Damora Therapeutics, Inc. SEC Filing (Aug 10, 2026)
Damora Therapeutics, Inc. (DMRA) filed a post-effective amendment to its S-3 registration statement on August 10, 2026. This amendment follows the company's redomestication from Delaware to the Cayman Islands on July 16, 2026, and clarifies that no new securities are being registered. The filing …
Damora Therapeutics Q2 Results: Net Loss Widens To $31.2 Million
Damora Therapeutics reported a net loss of $31.2 million for Q2 2026, a significant increase from $3.4 million in the prior year, primarily due to soaring R&D expenses for its CLARITY-101 trial. Despite the widening loss, the company boasts strong liquidity with $540.5 million …
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) announced its quarterly earnings, reporting a loss of $0.39 per share, which surpassed analysts' consensus estimate of a $0.45 loss by $0.06. Following the announcement, shares fell 1.3% to $29.54, resulting in a market capitalization of approximately $1.82 …
Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Damora Therapeutics, Inc. announced its financial results for the second quarter and first six months of 2026, ending June 30th. The company reported a significant increase in net loss for both periods compared to the previous year. For the second quarter, the net loss …
Wall Street Divided on Diamondback Energy as Jefferies and Bernstein Issue Diverging Price Target Revisions
Wall Street analysts are showing mixed signals on Diamondback Energy (FANG), with Jefferies raising its price target to $205 while maintaining a Hold rating, and Bernstein lowering its target to $221 but keeping an Outperform rating. Despite these differing revisions, the overall analyst consensus, …
Diamondback Energy On Pace for Largest Percent Increase Since April 2025 -- Data Talk
Diamondback Energy, Inc. (FANG) is experiencing a significant surge, currently up 5.35% at $198.10, putting it on track for its largest percentage increase since April 2025. This performance makes it the ninth best performer in the S&P 500 and fourth best in the Nasdaq …